Mark A Sullivan is a notable inventor based in Fairport, NY (US). He has made significant contributions to the field of immunology, holding a total of 9 patents. His work focuses on developing innovative solutions for treating infections and enhancing orthopedic procedures.

Latest Patents

One of his latest patents is titled "Anti-glucosaminidase passive immunization for infections." This invention is directed towards a monoclonal antibody that specifically binds to a glucosaminidase, inhibiting its in vivo growth. The patent also discloses monoclonal antibody binding portions, recombinant or hybridoma cell lines, and pharmaceutical compositions containing the monoclonal antibody or its binding portions. Furthermore, it outlines methods for treating infections and osteomyelitis, as well as techniques for introducing orthopedic implants into patients using the monoclonal antibody or its pharmaceutical compositions.

Career Highlights

Mark A Sullivan is affiliated with the University of Rochester, where he continues to advance his research and innovations. His work has garnered attention in the medical community, particularly for its potential applications in treating serious infections and improving patient outcomes.

Collaborations

He has collaborated with esteemed colleagues such as Edward M Schwarz and John L Daiss, contributing to a rich environment of innovation and research.

Conclusion

Mark A Sullivan's contributions to the field of immunology and orthopedic medicine highlight his role as a leading inventor. His patents reflect a commitment to advancing healthcare through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.